Fiocruz in Antarctica - health and environmental surveillance facing the challenges of the 21st century.

Autor:	Brandão M; Oswaldo Cruz Foundation, Vice-Presidency of Production and Innovation in Health, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Marques L; Oswaldo Cruz Foundation, Global Health Center, Presidency, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Villela RV; Oswaldo Cruz Institute, Laboratory of Biology and Parasitology of Wild Mammals Reservoirs, Oswaldo Cruz Foundation, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Trilles L; Oswaldo Cruz Foundation, Laboratory of Mycology, Evandro Chagas National Institute of Infectology, Av. Brasil 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Vivoni A; Instituto Oswaldo Cruz, Laboratory of Bacteriology Applied to Single Health and Antimicrobial Resistance, Center for Research, Innovation and Surveillance in Covid-19 and Health Emergencies, Bl 2, sl 2-102, Av Brasil, 4036, Manguinhos, 21040-361 Rio de Janeiro, RJ, Brazil., Siqueira M; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Respiratory, Exanthematic, Enteric viruses and Viral Emergencies, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Ogrzewalska M; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Respiratory, Exanthematic, Enteric viruses and Viral Emergencies, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Gomes HM; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Molecular Biology applied to Mycobacteria, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Moreira L; Oswaldo Cruz Foundation, Laboratory of Mycology, Evandro Chagas National Institute of Infectology, Av. Brasil 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Magalhães MGP; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Applied Genomics and Bioinnovation - LAGABI, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Prado T; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Respiratory, Exanthematic, Enteric viruses and Viral Emergencies, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Parente TE; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Applied Genomics and Bioinnovation - LAGABI, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Duarte GF; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Applied Genomics and Bioinnovation - LAGABI, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil.; Universidade Federal do Rio de Janeiro, Av. Pedro Calmon, 550, Cidade Universitária, 21941-901 Rio de Janeiro, RJ, Brazil., Cruz M; Oswaldo Cruz Foundation, Social Communication Coordination, Presidency, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Miagostovich M; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Comparative and Environmental Virology, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Chame M; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Information Center on Wilderness Health and the Institutional Platform Biodiversity and Wilderness Health - Pibss/Fiocruz, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Soares SP; Oswaldo Cruz Foundation, Vice-Presidency of Production and Innovation in Health, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil., Degrave W; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Laboratory of Applied Genomics and Bioinnovation - LAGABI, Av. Brasil, 4365, Manguinhos, 21040-360 Rio de Janeiro, RJ, Brazil.
Jazyk:	angličtina
Zdroj:	Anais da Academia Brasileira de Ciencias [An Acad Bras Cienc] 2024 Jun 17; Vol. 96 (suppl 2), pp. e20230742. Date of Electronic Publication: 2024 Jun 17 (Print Publication: 2024).
DOI:	10.1590/0001-3765202420230742
Abstrakt:	FioAntar, FIOCRUZ's research project in Antarctica, is based on the One Health approach. FioAntar aims to generate relevant information that will help reduce the risk of future pandemics and improve the search for chemical compounds and new biological molecules. After four expeditions to Antarctica under the scope of PROANTAR, Fiocruz has identified Influenza H11N2 virus in environmental fecal samples, as well as Histoplasma capsulatum and Bacillus cereus in soil samples. In addition, in a prospective virome analysis from different lakes in the South Shetland Islands, six viral orders were described, supporting future research related to the biodiversity and viral ecology in this extreme ecosystem. Our findings of environmental pathogens of public health importance are a warning about the urgency of establishing a surveillance agenda on zoonoses in Antarctica due to the imminent risks that ongoing environmental and climate changes impose on human health across the planet. FioAntar strives to establish a comprehensive surveillance program across Antarctica, monitoring circulation of pathogens with the potential to transcend continent boundaries, thereby mitigating potential spread. For Fiocruz, Antarctica signifies a new frontier, teeming with opportunities to explore novel techniques, refine established methodologies, and cultivate invaluable knowledge.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu